Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 Ansichten
• 07/18/23
0
0
Einbetten
administrator
Abonnenten
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare